• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID Back to Search Results
Model Number M001719060
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hypersensitivity/Allergic reaction (1907); Swelling/ Edema (4577)
Date of Event 09/25/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that patient experienced allergic reaction post stent implantation.A 10x37,5.9f,135cm carotid wallstent was implanted in the patient.Post stent implantation, patient experienced systemic hives, welts, angioedema, and an anaphylactic reaction.The patient had been placed on many steroids and seen 3 allergists to date.
 
Additional Manufacturer Narrative
B3 - date of event: date of event was approximated to 09/25/2025 as the exact event date was not reported.
 
Additional Manufacturer Narrative
B3 - date of event: date of event was approximated to 09/25/2025 as the exact event date was not reported.Device history record (dhr) review: it was confirmed this device met manufacturing specifications prior to distribution and there were no manufacturing deviations that could have contributed to the reported event.Labeling review: review of the instructions for use (ifu) confirmed that the content was sufficient and did not contribute to the reported event; therefore, no updates are required to the document at this time.Risk review: a review of the carotid wallstent device was completed and confirmed that the events of allergic reaction and edema were defined in the risk documentation.The event types have been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Event or Problem Description
It was reported that patient experienced allergic reaction post stent implantation.A 10x37,5.9f,135cm carotid wallstent was implanted in the patient.Post stent implantation, patient experienced systemic hives, welts, angioedema, and an anaphylactic reaction.The patient had been placed on many steroids and seen 3 allergists to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAROTID WALLSTENT
Common Device Name
STENT, CAROTID
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key24484123
Report Number2124215-2026-11371
Device Sequence Number12006904
Product Code NIM
UDI-Device Identifier08714729781141
UDI-Public(01)08714729781141(17)280411(10)35049980
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P050019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/01/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberM001719060
Device Catalogue NumberM001719060
Device Lot Number0035049980
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/03/2026
Supplement Date Received by Manufacturer03/04/2026
Initial Report FDA Received Date03/02/2026
Supplement Report FDA Received Date04/01/2026
Date Device Manufactured10/11/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-